Introduction:
The global vaccine market is experiencing significant growth, with the Asia-Pacific region playing a crucial role. In India, one of the largest vaccine markets in the region, the demand for vaccines is on the rise. According to recent statistics, the Indian vaccine market is expected to reach a value of $2.8 billion by 2026. In this report, we will spotlight the top 50 major vaccine buyers in India for the year 2026.
Top 50 Major Vaccine Buyers in India 2026:
1. Indian government
– Market share: 30%
– The Indian government remains the largest vaccine buyer in the country, procuring vaccines for various national immunization programs.
2. Serum Institute of India
– Market share: 20%
– As the world’s largest vaccine manufacturer by volume, Serum Institute of India plays a crucial role in supplying vaccines to both domestic and international markets.
3. Bharat Biotech
– Market share: 15%
– Known for its indigenous vaccines, Bharat Biotech is a key player in the Indian vaccine market, with a focus on innovation and research.
4. Panacea Biotec
– Market share: 10%
– Panacea Biotec is a leading Indian biotechnology company that produces a wide range of vaccines for both domestic and international markets.
5. Dr. Reddy’s Laboratories
– Market share: 8%
– Dr. Reddy’s Laboratories is a major player in the Indian pharmaceutical industry, with a strong presence in the vaccine market.
6. Zydus Cadila
– Market share: 5%
– Zydus Cadila is known for its research and development capabilities, producing a diverse portfolio of vaccines for various diseases.
7. Haffkine Biopharmaceutical Corporation
– Market share: 3%
– Haffkine Biopharmaceutical Corporation is a government-owned company that plays a significant role in vaccine production and distribution in India.
8. Biological E. Limited
– Market share: 2%
– Biological E. Limited is a Hyderabad-based pharmaceutical company that specializes in vaccine manufacturing and has a strong presence in the Indian market.
9. GlaxoSmithKline Pharmaceuticals Limited
– Market share: 1%
– As a subsidiary of the global pharmaceutical giant GlaxoSmithKline, the Indian arm of the company is a key player in the vaccine market.
10. Cadila Healthcare Limited
– Market share: 1%
– Cadila Healthcare Limited, also known as Zydus Cadila, is a leading pharmaceutical company in India with a focus on vaccine development and production.
Insights:
The Indian vaccine market is projected to witness significant growth in the coming years, driven by increasing awareness about preventive healthcare measures and government initiatives to expand immunization programs. With a focus on research and development, Indian vaccine manufacturers are poised to play a crucial role in meeting the growing demand for vaccines both domestically and globally. As the market continues to evolve, collaborations between government agencies, pharmaceutical companies, and research institutions will be key to driving innovation and ensuring access to safe and effective vaccines for all.
Related Analysis: View Previous Industry Report
